Authors Posts by Joshua Rodriguez

Joshua Rodriguez

2992 POSTS 445 COMMENTS
Hey everyone, I'm Joshua Rodriguez. I'm the founder of CNA Finance as well as several other sites. If you'd like to connect with me, follow me on or Twitter! I'd love to see ya there. Also, if you're looking for top quality content for your blog, news outlet, or any other website for that matter, please reach out to me at Info@CNAFin.com! Legal Disclaimer - CNA Finance is NOT an investment advisor. All investment decisions should be well thought out and made with the help of a an investment advisor. For our full legal disclaimer, please scroll to the bottom right of this page.

Freeport-McMoRan Inc FCX Stock News

Freeport-McMoRan Inc (NYSE: FCX) is off to an incredibly strong start to the trading session today, and for good reason. The company reported earnings, and while EPS came in slightly lower than expected, strong revenue is proving to be a source of excitement among investors. Of course, our partners at Trade Ideas were the first to alert us to the gains. At the moment (10:36), FCX is trading at $14.57 per share after a gain of $1.61 per share or 12.42% thus far today.





FCX Gains On Strong Earnings

As mentioned above, Freeport-McMoRan is having an incredibly strong day in the market today after releasing its results for the second quarter. While earnings slightly missed their mark, investors seem to have a keen focus on revenue, which proved to be positive. Here’s what we saw from the report…




  • Earnings Per Share – When it comes to earnings per share, FCX didn’t have the best quarter in the world. During Q2, analysts expected that the company would generate $0.20 per share in earnings. However, the company missed the mark by $0.03, reporting earnings per share in the amount of $0.17.
  • Revenue – Although revenue didn’t quite hit the mark for the second quarter, FCX did incredibly well when it came to top-line revenue. During the quarter, analysts expected that the mining company would generate revenue in the amount of $3.66 billion. However, the company actually generated revenue in the amount of $3.71 billion, topping expectations.

Another big factor here is copper prices. While the company did reduce its guidance with regard to the total amount of copper it plans on producing throughout the year, that is likely to largely be offset by an increase in prices. This increase is being caused by a mix between a weak USD and growing copper demand in China.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on FCX. In particular, we’re interested in following copper prices, as gains there seem to be the primary driver of gains in the stock to come. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









Gevo, Inc. GEVO Stock News

Gevo, Inc. (NASDAQ: GEVO) is having a great day in the market thus far today, and for good reason. The company announced that its isobutanol is now ready for licensing. Of course, this led to excitement among investors, prompting gains in the stock and leading to an alert from our partners at Trade Ideas. At the moment (10:03), GEVO is trading at $0.79 per share after a gain of $0.07 per share (9.03%) thus far today.





GEVO Announces Isobutanol Licensing Availability

As mentioned above, Gevo is having an incredibly strong day in the market today after a key announcement that was made at the BIO World Congress on Industrial Biotechnology in Montreal, Canada. Praj and Gevo jointly announced that isobutanol technology will now be available for licensing to processors of sugar cane juice and molasses.




In the Gevo’s technology using sugar cane and molasses feedstocks. This led to the development and process design package that is now available for commercialization of cane juice and molasses-based ethanol plants. It is expected that this licensing will be focused on Praj plants that are located in India, South America, and Southeast Asia. The initial capacity under the agreement is targeted to come online between 2019 and 2020. In a statement, Dr. Patrick Gruber, CEO at GEVO, had the following to offer:

We are pleased with the work that Praj has done in adapting our technology using cane juice and molasses as feedstocks. Praj is a great partner who shares our vision of low carbon fuels made from sugars in high yields. Praj has a massive footprint across the world. We look forward to working with Praj to license the technology out, leveraging their access and capabilities…”

The above statement was followed up by Pramod Choudhari, Executive Chairman at Praj. Here’s what he had to say:

We are excited to offer this technology to our global customers who stand to benefit from an additional revenue stream from isobutanol. Praj has worked on 750 projects for ethanol plants across 75 countries. This isobutanol platform can be offered as ‘bolt-on’ to an existing ethanol plant or as a greenfield plant. This isobutanol technology is the latest addition to Praj’s diverse product portfolio and reinforces our organization’s leadership in the bioenergy space.”

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on GEVO. In particular, we’re interested in watching to see how the agreement with Praj turns into revenue and profits as the isobutanol technology is licensed out. We’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









AK Steel Holding Corporation AKS Stock News

AK Steel Holding Corporation (NYSE: AKS) is having an overwhelmingly strong day in the market today, and for good reason. The company announced earnings, proving to have a much better quarter than expected. This led to excitement among investors, causing gains and prompting our partners at Trade Ideas to alert us to the movement. At the moment (9:49), AKS is trading at $6.62 per share after a gain of $0.59 per share or 9.87% thus far today.





AKS Reports Strong Earnings

As mentioned above, AK Steel is having an overwhelmingly strong start to the trading session this morning after reporting earnings for the second quarter. Here’s what we saw from the report…




  • Revenue – In terms of revenue, AKS did incredibly well. During the quarter, analysts expected that the company would generate revenue in the amount of $1.46 billion. However, the company actually generated revenue in the amount of $1.56 billion. Not only did that beat estimates by $10 million, but it also proved to be a 4.7% year over year gain.
  • Earnings – Earnings was another area where AKS definitely did not disappoint. During the quarter, analysts expected that the company would generate earnings in the amount of $0.12 per share. However, the company actually reported earnings in the amount of $0.19 per share.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on AKS. In particular, we’re interested in watching to see if the growth will continue. While shipments were down, the company was able to leverage pricing and bring the growth. We’re excited to see if this will continue. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









Diana Containerships DCIX Stock News

Diana Containerships Inc (NASDAQ: DCIX) is having an overwhelmingly strong start to the trading session in the pre-market hours today, and for good reason. The company reported its earnings for the second quarter, causing excitement among investors and leading to gains. Of course, our partners at Trade Ideas were the first to alert us to the gains. At the moment (9:19), DCIX is trading at $0.73 per share after a gain of $0.23 per share (45.98%) thus far today.





DCIX Flies On Earnings

As mentioned above, Diana Containerships is having an overwhelmingly strong start to the day in the pre-market hours after reporting its earnings for the second quarter. The earnings showed incredible year-over-year growth. Here’s what we saw:




  • Sales – While sales came in a bit lower than expected, earnings per share clearly blew expectations out of the water. We’ll get to earnings in a second; let’s start with sales. During the quarter, analysts expected that DCIX would generate $6.8 million in sales. However, the company actually generated sales in the amount of $5.498 million.
  • Earnings – While sales didn’t quite hit the mark, earnings definitely proved to be great. During the second quarter, the company generated earnings per share in the amount of $17.27. That’s an incredible jump from the loss of $6.13 per share that the company experienced in the same quarter last year.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will continue to keep a close eye on DCIX. In particular, we’re interested in seeing if the company can keep the exceptional earnings growth coming. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









Youngevity International YGYID Stock News

Youngevity International Inc (NASDAQ: YGYI) is likely to have a strong day in the market today after announcing that it has appointed a new member of the management team. This comes after a slurry of news on the stock and shortly following the company’s listing on the NASDAQ.





YGYI Welcomes Luke Taffuri To The Management Team

As mentioned above, Youngevity International is likely to have a strong day in the market after announcing the appointment of Luke Taffuri to its management team. Taffuri has been appointed as the VP of International Sales and Operations. With him. Mr. Taffuri brings more than 22 years of direct selling experience in various positions. One of those positions was the Chief Operating Officer at Sorvana International, a company that YGYI recently acquired.




This is an important piece of news. After all, YGYI has been building the list of countries in which it operates. This combined with recent acquisitions that have increased geographic expansion, the need for a management position in the international sales and operations space has grown. Today, YGYI is operating in eight Asian Markets while growing its presence in Latin America and Eastern Europe. In a statement, Steve Wallach, Chairman and CEO at Youngevity, had the following to offer…

Our entire management team is very excited to announce the creation of the VP of International Sales and Operations role, and believe we found the perfect candidate in Luke Taffuri. As we continue to transition into a global company, we believe Luke’s experiences and industry relationships should optimize the international growth potential that exist in Youngevity today.”

The above statement was followed up by Mr. Taffuri, who had the following to offer…

I am impressed with what Youngevity has in place for their current international markets from an operational, technological, and product offering standpoint. I am most impressed, however, with the quality of the people and the culture that has been built throughout the organization. They have a great foundation illustrated by their 20 year history which I believe will lead to more efficient and productive transitions in the international marketplace. Initially I will focus on driving revenue growth across the global platform. As markets begin to scale I will set my sites on operational efficiencies and profitability.”

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on YGYI. In particular, we’ll be watching to see how Mr. Taffuri expands revenue and profitability on the global scale. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









Top Ships TOPS Stock News

Top Ships Inc (NASDAQ: TOPS) is having an overwhelmingly strong day in the market today as rumors start to surface surrounding the company. The rumor, suggesting that the company will soon see an acquisition, is causing excitement among investors, sending the stock upward and prompting our partners at Trade Ideas to alert us to the movement. At the moment (11:10), TOPS is trading at $0.60 per share after a gain of $0.34 per share (129.12%) thus far today.





TOPS Gains On Takeover Speculation

As mentioned above, Top Ships is having a strong time in the market today after rumors started to pop up that the company will soon be acquired. The rumors started to fly yesterday when they were started by Sierra World Equity Review. On the website, Sierra says that John Fredriksen is going to acquire TOPS within the next 30 days. While the publication does not suggest at what price the acquisition may happen, they seem to be adamant that it’s likely.




Keep in mind that we see rumors in the market all the time. Sierra World Equity Review has provided two of those rumors in the past month, the first of which didn’t pan out. Chances are that this is nothing more than speculation. At the end of the day, rumors are just that – they are rumors. So, if you’re going to trade on this, make sure to do so with caution.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on TOPS. In particular, we’re interested in finding out of Sierra got it right this time. While we don’t believe that this acquisition is going to take place, anything can happen in the market. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









0 882
Novavax, Inc. NVAX Stock News

Novavax, Inc. (NASDAQ: NVAX) is having yet another incredible day in the market today, and for good reason. Today is the day of a key update that investors have been waiting for. Of course, the excitement continues to build after the stock climbed around 50% since July 17th. As is almost always the case, our partners at Trade Ideas were the first to alert us to the gains. At the moment (10:44), NVAX is trading at $1.72 per share after a gain of $0.24 (16.22%) thus far today.





NVAX Climbs Ahead Of Update

As mentioned above, Novavax is having an incredible day in the market today as we get closer and closer to a very important conference call. The rally started on July 17th, after the company announced that it would be hosting a conference call and webcast today. The call will be held at 4:30 ET and the information to get involved is below.




This particular call surrounds topline data from a recent Phase 2 Safety and immunogenicty trial of the RSV-F vaccine the company has been working on for adults 60 years of age and older. NVAX also said that it will be providing updated information with regard to prior Phase 2 and Phase 3 clinical trials in older adults and its RSV Phase 3 clinical trial for infants via maternal immunization. Here is the agenda for the webcast:

  • First NVAX will announce topline data from the Phase 2 safety and immunogenicity trial in older adults.
  • The company then intends to provide additional findings associated with previous Phase 2 and Phase 3 clinical trials in older adults.
  • Finally, NVAX will provide an update on the Prepare(TM) clinical trial for infants via maternal immunization.

If you’d like to take part in the study, you can do so by either calling in or clicking at 4:30 ET tonight. Here’s the information:

  • Call In – If you plan on calling into the Novavax presentation, you can do so by calling (877) 212-6076 if you’re in the United States or calling (707) 287-9331 if you are not. The passcode for the call is 54820069.
  • On The Web – You can also log into the webinar by going to www.novavax.com.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on NVAX. In particular, we’ll be listening to the presentation later today, and we are overwhelmingly excited to learn more about the data. We’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









DryShips Inc. DRYS Stock News

DryShips Inc. (NASDAQ: DRYS) is having an overwhelmingly strong day in the market today, following serious losses experienced last week. It kind of reminds me of an old saying that my dad would utter when I tried to make something that was obviously bad look good. “You can polish a turd, but it will always be a turd!” Well, my friends, that’s what we have with DRYS. You can keep polishing if you’d like, but all you’ll end up with is a hand full of shiny crap!





DRYS Deserves Investigation, Not Support!

For some reason, and one that I simply can’t understand, DryShips is having yet another strong day in the market today. This is proving to be a repetitive process. So, for those of you who missed it the past several times, here’s how it all works.

It starts with DRYS processing a reverse stock split. That’s something that has taken place 5 times so far this year, and will likely take place more. From there, the stock falls dramatically. However, a few days later, we see a trader-fueled pop, like the one we’re seeing today. Over time, this money somehow disappears and DRYS finds itself trading below $1 per share yet again, leading to the next split. Classic pump and dump? You be the judge.




Illegal Activities With Kalani Investments

Another big piece of crap that seems to be closely tied to DryShips is known as Kalani Investments. Kalani is known for buying massive amounts of DRYS shares after dilution with the purpose of selling the stock quickly to make a quick buck. In fact, even the Wall Street Journal believes that these activities should be investigated. Here’s what Jill Fisch had to offer:

If [Kalani is] buying it with the intent to resell, then they’re acting as an underwriter and this is a public offering…”

There would be no problem with that if Kalani was registered with the Securities and Exchange Commission as an underwriter. However, they are not. Instead, they seem to be part of the fraudulent pump-and-dump activity that DRYS continues to take part in.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What Shareholders Should Do

At the end of the day, if you’ve held shares of DRYS throughout this year, you’ve lost a ton of value on your investment, and considering that the past is likely to be indicative of the future, the game playing by George Economou and the DryShips team is far from over. With that said, it’s time to fight back. It’s time to report the company to the SEC, and if enough people do, an investigation will take place, as it should! The bottom line here is that Economou has made it his mission to take money out of your pocket and put it into his. Stop playing the role he wants you to play and start asking the hard questions!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









0 1537
Dynavax Technologies Corporation DVAX Stock News

Dynavax Technologies Corporation (NASDAQ: DVAX) is off to an incredibly strong start in the trading session today, and for good reason. Early this morning, the company informed investors of an FDA advisory committee review of an experimental drug. Of course, this led to excitement among investors, sending the value of the stock toward the top. As is normally the case, our partners at Trade Ideas were the first to alert us to the gains. At the moment (9:42), DVAX is trading at $9.80 per share after a gain of $0.20 per share (2.08%) thus far today.





DVAX Gains On FDA Committee Review

As mentioned above, Dynavax Technologies is having an incredibly strong day in the market today after announcing that the United States Food and Drug Administration has informed the company that the Vaccines and Related Biological Products Advisory Committee will review HEPLISAV-B(TM) at its scheduled meeting which will take place on July 28th.




This is interesting, as the PDUFA date for HEPLISAV-B is only a few weeks away, coming in at August 10th. The FDA intends to communicate specific questions with the VRBPAC and will draft an agenda for the questions, which will be on its website at least 48 hours prior to the meeting. In a statement, Eddie Gray, CEO at DVAX, had the following to offer:

The notification of a VRBPAC meeting comes as no surprise and thus we are prepared for it… The company looks forward to continuing work with the FDA through the review process and discussing HEPLISAV-B with the advisory committee.”

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on DVAX. In particular, we’re interested in following the meeting with the VRBPAC and excited to learn whether or not the vaccine will find its way to approval, and subsequently, commercialization. We’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









0 373
Sarepta Therapeutics Inc SRPT Stock News

Sarepta Therapeutics Inc (NASDAQ: SRPT) is having a rough start to the day today in the pre-market hours, and for good reason. The company announced an offering this morning that’s proving to be a cause for concern among investors. Of course, our partners at Trade Ideas were the first to alert us to the declines. At the moment (8:58), SRPT is trading at $42.15 per share after a loss of $1.26 per share (2.90%) thus far today.





SRPT Announces Offering

As mentioned above, Sarepta Therapeutics is having a rough start to the day in the pre-market hours today after announcing an offering. The company announced today that it plans to sell $250 million in shares of common stock in an underwritten public offering. The company also hopes to grant the underwriters a 30-day option to purchase an additional $37.5 million in shares of common stock.




The first purchase in this offering is likely to come from Douglas Ingram, the President and CEO at SRPT. In fact, he has expressed that he is interested in purchasing up to $2 million in stock at the offering price.

The offering will be done with the assistance of Goldman Sachs as well as J.P. Morgan Securities, as they act as joint book-running managers for the proposed offering. It was also announced that Credit Suisse Securities will be acting as a joint book-runner.

What Is The Money For?

SRPT said that the proceeds produced by the offering will be used largely for the continuation and initiation of further clinical trials, commercialization, and manufacturing, as well as business development activities. The company also said that the funds may be used in the potential licensing or acquisition of complementary products and technologies.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on SRPT. In particular, we’re interested in following the company as it moves through the offering and starts to use the funding. We’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









Thought Leader Discussions

Gevo, Inc. GEVO Stock News

0 5824
Gevo, Inc. (NASDAQ: GEVO) Before we get into this interview, I'd like to extend a special thanks to my friend Joey who both set up the...